Share your videos with the world

Sign Up | Log In | Help  

   
 
Related Tags: implantcenter  teeth  health  smile  surgery  treatment  budapest  multivu  8274651  health  hospital  medicine  healthcare  treatments  new  technology  northwestern  medicine  multivu  8213351  disease  health  research  healthcare  treatment  technology  new  help  wellness  multivu  8268751  pancreatic  cancer  health  disease  symposium  awareness  treatments  survivors  multivu  8213752  cancer  medical  health  hope  breast  cancer  survivor  cancer  survivor  book  trailer  claudia  bretzing  the  cancer  effect  cospro  pancreatic  cancer  health  awareness  disease  detection  early  prevention  diagnose  multivu  8201651  cancer  health  research  treatment  disease  2017  aacr  fda  multivu  8155051  childhood  cancer  tumor  health  research  hospital  st  jude  medical  overview  multivu  8121952  woman  health  comfort  replens  gel  dryness  vaginal  menopause  multivu  8066251  fda  brain  cancer  health  healthcare  treatment  medicine  glioma  multivu  7944251  johnson  johnson  medical  devices  health  healthcare  jjmd  cost  treatment  multivu  8119051  blink  health  health  healthcare  type  2  diabetes  treatment  medication  money  multivu  8117451 
Search // patients
Results 1-12 of 217 for ' patients ' (0 seconds)
The ImplantCenter has recently opened the brand-new operating room suited for more complex treatments. This comes alongside numerous additions such as the launch of the four cosy apartments to rest after treatments at the clinic and an implant education facility to expand their services further. These expansions are part of constant improvements that have been occurring for the last 15 years, alongside high quality service. The area of the clinic has increased by ten-fold to approximately 1800 m2 during the years. Moreover, the oral surgery division was opened in 2015, so eight dental treatment rooms and four oral surgery rooms are now in place today. All of the surgery rooms can serve ambulatory oral surgery treatments. The ImplantCenter is unique in Hungarian private dentistry because they can implement more complex treatments in the framework of one-day oral surgery procedure. This is due to the big and fully equipped operating room opened in November 2017. As part of the service, the ImplantCenter offers one and two-bed private rooms with medical supervision to their patients after each surgery. To view the multimedia release go to: https://www.multivu.com/players/uk/8274651-implantcenter-hungarian-dental-service/
Categories // Miscellaneous 
Added: 3 days ago by MultiVuVideos
Runtime: 1m3s | Views: 2 | Comments: 0
Not yet rated
 

 

 

After nearly eight years of careful planning, guests from across Illinois gathered today in Lake Forest to celebrate the ceremonial opening of the new Northwestern Medicine Lake Forest Hospital, which will officially open on March 3, 2018. The new state-of-the-art hospital, which broke ground in 2014, will provide patients convenient access to world-class physicians with seamless access to Northwestern Memorial Hospital, Illinois’s premier academic medical center when needed. The new Lake Forest Hospital will offer cutting-edge treatments and innovative clinical trials within a world class health system. To view the multimedia release go to: https://www.multivu.com/players/English/8213351-new-northwestern-medicine-lake-forest-hospital/
Categories // Miscellaneous 
Added: 11 days ago by MultiVuVideos
Runtime: 1m6s | Views: 4 | Comments: 0
Not yet rated
 

 

 

TransCelerate BioPharma Inc., a non-profit organization dedicated to improving the health of people around the world by simplifying and accelerating research and development of innovative new therapies, has unveiled a new global campaign designed to help increase awareness of the growing need for clinical trial participants. The campaign, called “One Person Closer,” focuses on inspiring healthcare professionals (HCPs) to consider clinical research as a possibility for their patients, incorporate the topic into their daily practices, and have meaningful conversations with patients about opportunities to participate in clinical trials. One Person Closer is designed to put a human face on research and development by sharing the personal stories of researchers, HCPs and patients who have contributed to clinical research and the development of medical breakthroughs. The photojournalist campaign aims to show doctors, nurses and other HCPs that they can help facilitate research that advances science and that may benefit their patients. To view the multimedia release go to: https://www.multivu.com/players/English/8268751-transcelerate-biopharma-one-person-closer/
Categories // Miscellaneous 
Added: 17 days ago by MultiVuVideos
Runtime: 1m28s | Views: 4 | Comments: 0
Not yet rated
 

 

 

Let’s Win, an initiative supported by the Lustgarten Foundation, launched the Let’s Win! Pancreatic Cancer Survivors video series Friday, January 19, 2018, at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium. The new online video series, featuring long-term pancreatic cancer survivors of all ages and diverse backgrounds, has been created to show pancreatic cancer patients and their families that people do survive this disease. The survivors have responded exceptionally well to pancreatic cancer therapy that incorporates clinical trials and treatments that go beyond traditional protocols. When patients are first diagnosed with pancreatic cancer, they often turn to the internet, only to find devastating and frightening statistics about the disease. “Our goal is to provide hope and inspiration to patients and their families,” says Cindy Gavin, founding executive director of Let’s Win. “We are so grateful for the incredible vision of one special patient and the generosity of The Flora Family Foundation for their support of this incredible initiative.” To view the multimedia release go to: https://www.multivu.com/players/English/8213752-lets-win-pancreatic-cancer-survivor-video-series/
Categories // Miscellaneous 
Added: 32 days ago by MultiVuVideos
Runtime: 3m51s | Views: 5 | Comments: 0
Not yet rated
 

 

 

The Cancer Effect is the inspiring true story of one woman’s journey with cancer, written to provide hope and healing for patients, survivors, and those who love them. Moving, enlightening, uplifting, and honest. Learn more about this powerful memoir at www.claudiabretzing.com Non-fiction/self help
Categories // Miscellaneous 
Added: 78 days ago by cosproductions
Runtime: 1m16s | Views: 2 | Comments: 0
Not yet rated
 

 

 

In honor of World Pancreatic Cancer Day on Nov. 16, people around the world will come together to Demand Better in the fight against the world’s toughest cancer, starting with earlier diagnosis. The annual one-day campaign is an initiative of the World Pancreatic Cancer Coalition, which is comprised of more than 60 organizations from 27 countries on six continents. Every day, more than 1,000 people worldwide will be diagnosed with pancreatic cancer. Of that, an estimated 985 will die from the disease. Additionally, pancreatic cancer has the lowest survival rate among all major cancers, and in nearly every country, it is the only major cancer with a single-digit five-year survival rate (2-9 percent). These stunning figures are not merely statistics, they represent family members, friends and colleagues on every corner of the globe. “This year, we are turning World Pancreatic Cancer Day from a day of awareness to a day of action,” said Julie Fleshman, JD, MBA, World Pancreatic Cancer Coalition chair. “As we expand our global movement to end pancreatic cancer, we are demanding better for pancreatic cancer patients now and in the future.” To view the multimedia release go to: https://www.multivu.com/players/English/8201651-world-pancreatic-cancer-day-demand-better/
Categories // Miscellaneous 
Added: 121 days ago by MultiVuVideos
Runtime: 1m3s | Views: 9 | Comments: 0
Not yet rated
 

 

 

Federally funded research that provides a deep understanding of cancer is spurring advances against many types of the disease. With a strong bipartisan commitment from Congress to keep investment in biomedical research a national priority, we can accelerate our pace of progress and save more lives from cancer, according to the seventh annual American Association for Cancer Research (AACR) Cancer Progress Report, released today. Basic research in the fields of immunology and cancer genetics has recently been harnessed to develop two new forms of cancer treatment: immunotherapy and precision medicine. As detailed in the report, the utility of these treatments is expanding rapidly. In May 2017, the U.S. Food and Drug Administration (FDA) heralded a new dawn for precision medicine when it approved the immunotherapeutic pembrolizumab (Keytruda) for treating patients with any solid tumor harboring specific genetic characteristics. This is the first anticancer therapeutic approved based on cancer biomarkers rather than the location in the body where the cancer originated. To view the multimedia release go to: https://www.multivu.com/players/English/8155051-aacr-cancer-progress-report-2017/
Categories // Miscellaneous 
Added: 164 days ago by MultiVuVideos
Runtime: 1m0s | Views: 7 | Comments: 0
Not yet rated
 

 

 

In an effort to improve outcomes for patients with some of the deadliest childhood cancers, St. Jude Children’s Research Hospital scientists have created the world’s largest collection of pediatric solid tumor samples, drug-sensitivity data and related information and have made the resource available at no charge to the global scientific community. St. Jude and the Howard Hughes Medical Institute collaborated to create the resource, known as the Childhood Solid Tumor Network. The work is reported today as an advance online publication in the scientific journal Nature. “Survival rates for children with recurrent solid tumors have not improved significantly in more than 20 years and remain below 30 percent,” said corresponding author Michael Dyer, Ph.D., chair of the St. Jude Department of Developmental Neurobiology and a Howard Hughes Medical Institute investigator. “This research will change that by promoting scientific collaboration to leverage the efforts of researchers worldwide to advance understanding and ultimately treatment of pediatric solid tumors.” To view the multimedia release go to: https://www.multivu.com/players/English/8121952-st-jude-childrens-childhood-solid-tumor-network/
Categories // Miscellaneous 
Added: 177 days ago by MultiVuVideos
Runtime: 1m34s | Views: 2 | Comments: 0
Not yet rated
 

 

 

The complete solution to managing vaginal dryness and discomfort inside and out is now available to the millions of women changing physically, emotionally and hormonally every day. The maker of #1 doctor recommended Replens™ vaginal moisturizer introduces hormone-free and fragrance-free Replens™ Moisture Restore External Comfort Gel, for soothing relief from external vaginal dryness, in menopause, post-partum, and after a cancer diagnosis. “Ladies, don’t despair. Vaginal dryness can be a nuisance at any age. It’s one of the most common symptoms of menopause and unfortunately, can worsen over time. Luckily, there are non-hormonal products like Replens,” says Mary Jane Minkin, M.D., Clinical Professor of Obstetrics, Gynecology and Reproductive Sciences at Yale University. “I recommend these products to patients as first line therapies to help relieve internal and external vaginal dryness.” To view the multimedia release go to: https://www.multivu.com/players/English/8066251-replens-vaginal-moisture-restore-external-comfort-gel/
Categories // Miscellaneous 
Added: 193 days ago by MultiVuVideos
Runtime: 0m52s | Views: 2 | Comments: 0
Not yet rated
 

 

 

A first-of-a-kind neural stem cell therapy that works with a common cold virus to seek out and attack a lethal and aggressive brain cancer is being tested at Northwestern Medicine in a Phase I clinical trial for patients newly diagnosed with malignant glioma. The novel drug to treat malignant glioma, notorious for recurring after typical bouts of standard cancer treatment, was developed by a Northwestern scientist and has been approved as an investigational drug by the U.S. Food and Drug Administration. This is only the second time the University has supported and filed an investigational new drug as a sponsor. To view the multimedia release go to: https://www.multivu.com/players/English/7944251-northwestern-medicine-stem-cell-trial/
Categories // Miscellaneous 
Added: 247 days ago by MultiVuVideos
Runtime: 4m28s | Views: 8 | Comments: 0
Not yet rated
 

 

 

Leveraging 130 years of knowledge and expertise across the Johnson & Johnson Family of Companies, Johnson & Johnson Medical Devices (JJMD) is proud to launch a new approach to help drive value-based healthcare in hospitals across Europe, Middle East and Africa (EMEA) – CareAdvantage. This is a data-driven, holistic approach in which JJMD partners with hospitals and other healthcare providers to provide a range of benefits, tailored to the customer’s specific needs and priorities. The healthcare marketplace is changing, with intensifying pressure to meet the ‘triple aim’ of improving outcomes, increasing patient satisfaction and reducing costs. As the focus shifts from volume to value, there is a growing need for new delivery models, resulting in rapid transformation for hospital systems, clinicians and their patients. To view the multimedia release go to: https://www.multivu.com/players/uk/8119051-johnson-medical-devices-careadvantage/
Categories // Miscellaneous 
Added: 257 days ago by MultiVuVideos
Runtime: 2m14s | Views: 2 | Comments: 0
Not yet rated
 

 

 

Blink Health, America’s leading prescription drug savings platform, today launched a program to help #TreatType2 diabetes by committing to give away $10 million worth of medication to patients with type-2 diabetes. People living with diabetes who create an account on Blink Health’s website or free mobile app, starting today, will receive a free, one-year supply of the three most commonly prescribed generic medications for type-2 diabetes: metformin, glipizide and pioglitazone. The program will also cover these three medications for existing Blink Health patients who use them. To view the multimedia release go to: https://www.multivu.com/players/English/8117451-blink-health-type-2-diabetes-medications/
Categories // Miscellaneous 
Added: 261 days ago by MultiVuVideos
Runtime: 0m15s | Views: 5 | Comments: 0
Not yet rated
 

 

 

Page 1 of 19  |  Go to page    Next» LAST»»



About Us   |   Help  |   Advertise on ClipMoon   |   Terms of Use   |   Privacy Policy   |   Copyright   |   Contact   |   Link us   |   RSS 
Copyright © 2007-2018 ClipMoon.com. All rights reserved.